IDT signs contract to supply Research Councils UK with custom oligonucleotides
Integrated DNA Technologies has signed a three year contract with Research Councils UK (RCUK) for the supply of synthetic oligonucleotides. RCUK coordinates the UK’s seven research councils, enhancing the overall impact and effectiveness of the research they fund. As one of the preferred suppliers of custom oligonucleotides, IDT’s expert production technologies will aid RCUK in delivering on the UK government’s objectives for science and innovation. Each year RCUK invests approximately £2.5 billion in research, covering a broad spectrum of academic disciplines from medical and biological sciences, to astronomy, physics and chemistry.
“It is fantastic news that we have been selected as a preferred supplier by RCUK. We want researchers in the UK to benefit from IDT’s twenty-year commitment to tireless innovation and peerless quality in oligo synthesis. We can also use this opportunity to learn how IDT can best support research worldwide, as the science and application of synthetic biology advances,” commented Dr. Joseph A. Walder, IDT’s founder and CEO.
Organizations
Other news from the department business & finance

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
More news from our other portals
Last viewed contents
Anti-centromere_antibodies
Scripps scientists develop test providing new pathway for identifying obesity, diabetes drugs
U of M researchers develop a molecular 'calcium sponge' to tackle heart failure
Novartis to restructure US business - US General Medicines restructuring results in reduction of 1,960 positions
Karl_Wilhelm_von_Nägeli

Chemists find way to create "the building blocks of life" - Turning alcohol into key ingredients for new medicines
Nasopharyngeal_carcinoma
Smaller and Sharper: Nanoscale Metal–Organic Frameworks (NMOFs) as MRI Contrast Agents
Adenoid_cystic_carcinoma
Zona_incerta
